Literature DB >> 10756085

Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse.

N Abiru1, D Wegmann, E Kawasaki, P Gottlieb, E Simone, G S Eisenbarth.   

Abstract

T cells isolated from islets of non-obese diabetic (NOD) mice are enriched for insulin-reactive cells. The great majority of these T cells recognize insulin B chain peptide (B:9-23). B:9-23 reactive T cell clones are diabetogenic and show a dramatic TCR alpha -chain restriction (predominant AV13S3). We have studied the reactivity of five different B:9-23 reactive T cell clones to truncated peptides and alanine substituted analogues of B:9-23. Amongst these AV13S3 T cell clones, one reacted with peptide B:9-16 and four with B:13-23. The two peptides have in common only four amino acids (B:13-16; EALY). Having defined minimal peptide epitopes, we evaluated a mutant insulin sequence (B:13 glutamine) which retains metabolic activity. As predicted, this single amino acid change abrogated T cell reactivity. In addition, we have created a modified I-A(g7)gene with the B:9-23 peptide covalently linked to I-A(g7). Antigen presenting cells transfected with this construct were excellent presenting cells for all clones studied. The definition of dual peptide motifs and creation of bioactive covalent I-A(g7)-B:9-23 should facilitate studies of the pathogenic significance and antigen recognition by B:9-23 reactive diabetogenic T cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10756085     DOI: 10.1006/jaut.2000.0369

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  28 in total

1.  Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register.

Authors:  Brian D Stadinski; Li Zhang; Frances Crawford; Philippa Marrack; George S Eisenbarth; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

Review 2.  Treg vaccination with a strong-agonistic insulin mimetope.

Authors:  Benno Weigmann; Carolin Daniel
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

3.  Conserved T cell receptor alpha-chain induces insulin autoantibodies.

Authors:  Masakazu Kobayashi; Jean Jasinski; Edwin Liu; Marcella Li; Dongmei Miao; Li Zhang; Liping Yu; Maki Nakayama; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-14       Impact factor: 11.205

4.  Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse.

Authors:  Frances Crawford; Brian Stadinski; Niyun Jin; Aaron Michels; Maki Nakayama; Philip Pratt; Philippa Marrack; George Eisenbarth; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

5.  Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.

Authors:  Maki Nakayama; Norio Abiru; Hiroaki Moriyama; Naru Babaya; Edwin Liu; Dongmei Miao; Liping Yu; Dale R Wegmann; John C Hutton; John F Elliott; George S Eisenbarth
Journal:  Nature       Date:  2005-05-12       Impact factor: 49.962

6.  Antibodies to post-translationally modified insulin in type 1 diabetes.

Authors:  Rocky Strollo; Chiara Vinci; Mayda H Arshad; David Perrett; Claudio Tiberti; Francesco Chiarelli; Nicola Napoli; Paolo Pozzilli; Ahuva Nissim
Journal:  Diabetologia       Date:  2015-09-08       Impact factor: 10.122

Review 7.  Peptide antigens for gamma/delta T cells.

Authors:  Willi K Born; Li Zhang; Maki Nakayama; Niyun Jin; Jennifer L Chain; Yafei Huang; M Kemal Aydintug; Rebecca L O'Brien
Journal:  Cell Mol Life Sci       Date:  2011-05-08       Impact factor: 9.261

8.  High affinity binding of hydrophobic and autoantigenic regions of proinsulin to the 70 kDa chaperone DnaK.

Authors:  Volker Burkart; Rahel K Siegenthaler; Elias Blasius; Koen Vandenbroeck; Iraide Alloza; Waltraud Fingberg; Nanette C Schloot; Philipp Christen; Hubert Kolb
Journal:  BMC Biochem       Date:  2010-11-08       Impact factor: 4.059

Review 9.  Insulin as an autoantigen in NOD/human diabetes.

Authors:  Li Zhang; Maki Nakayama; George S Eisenbarth
Journal:  Curr Opin Immunol       Date:  2008-02       Impact factor: 7.486

Review 10.  Immunotherapy in autoimmune type 1 diabetes.

Authors:  Benno Weigmann; Randi K Franke; Carolin Daniel
Journal:  Rev Diabet Stud       Date:  2012-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.